期刊文献+

慢性充血性心力衰竭患者C-反应蛋白、肾上腺髓质素及内皮素-1水平比较

A comparison between C-reactive protein,adrenomedullin and endothelin-1 in patients of chronic congestive heart failure
原文传递
导出
摘要 目的研究心力衰竭时细胞因子激活后C-反应蛋白(CRP)的变化及对肾上腺髓质素(ADM)及内皮素-1(ET-1)等血管活性物质的影响。方法CRP采用散射比浊法测定,ET-1及ADM采用放射免疫分析法测定。对60例失代偿性心功能衰竭患者(心力衰竭组)及30例心功能正常的原发性高血压患者(对照组)血浆CRP、ADM及ET-1的浓度进行测定。结果心力衰竭组血浆CRP、ADM及ET-1浓度较对照组均明显升高;在心力衰竭组,不同心功能(NYHA)分级的患者随心功能衰竭加重,血浆CRP及ADM的浓度均有所升高,而ET-1浓度在不同心功能分级的患者中无显著差异;心力衰竭组患者血浆CRP浓度及ADM浓度呈正相关。结论慢性充血性心力衰竭患者体内存在着细胞因子、ADM及ET-1的激活,细胞因子活化可能通过促进ADM等的合成作用于心力衰竭的体液调节,但与ET-1的活化没有明显的关系。 Objective To study the changes of cytokine activation in patients with chronic congestive haert failure(CHF) as indicated by plasma levels of C-reactive protein(CRP) and its relation to adrenomedullin(ADM) and endthelin-1(ET-1). Methods The plasma levels of CRP,ADM and ET-1 of 60 decompensated haert failure(DHF) patients group and 30 essential hypertension patients with compensated cardiac function(CCF) group were tested. CRP was determined by immunoturbidometry, ET-1 and ADM were determined by radioimmunoassay. Results The plasma levels of ET-1 ,ADM and CRP of decompensated heart failure group were significantly higher than the compensated cardiac function group;In the decompensated heart failure group,the plasma levels of CRP and ADM were elevated according to worsening of heart failure(NYHA classification); In the decompensated heart failure group, the plasma levels of CRP were positively correlated with ADM ( r = 0.57). Conclusion There is extensive activation of cytokines,ADM and ET-1 in patients with chronic congestive heart failure. Cytokine activation might play a role in the synthesis of ADM,thus contribute to the hum oral regulation of heart failure,but may not be responsible for the activation of ET-1.
出处 《中国基层医药》 CAS 2006年第8期1250-1251,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 心力衰竭 充血性 C-反应蛋白 肾上腺髓质素 内皮素 Heart failure, congestive C-reactive protein Adrenomedullin Endothelin
  • 相关文献

参考文献5

二级参考文献34

  • 1田青,杨青,卢传义,唐朝枢.一种新发现的降压活性多肽──肾上腺髓质素(adrenomedullin)[J].生理科学进展,1995,26(2):149-151. 被引量:6
  • 2赵东,田青,赵云涛,宫长宁,韩启德,张肇康,汤健.肾上腺髓质素(13-52)降压机制的探讨[J].生理学报,1995,47(3):218-224. 被引量:18
  • 3李田昌,佟利家,庞永正,刘秀华,王雪清,胡大一,唐朝枢.丝裂素活化蛋白激酶参与内皮素刺激的兔主动脉平滑肌细胞增生[J].生理学报,1996,48(4):337-342. 被引量:13
  • 4石湘芸,张昭馥,赵云涛,聂智群,田青,唐朝枢,汤健,张肇康.原发性高血压患者血浆肾上腺髓质素水平的初步观察[J].中华核医学杂志,1996,16(4):266-267. 被引量:15
  • 5Meeran K, O' shen D, Upton PD, et al. Circulating adrenomedullin dose not regulate systemic blood pressure but increase plasma prolactin after intravenous infusion in humans: apbarmacokinetic study. J Clin Endocrinol Metab, 1997, 82:95--100.
  • 6Sakata M, Shimokawa A, Kunitake T, et al. Central actions of adrenomedullin on cadiovscular parameters and sympathetic outflow in conscious rats. Am J Physiol, 1998, 274 : 979--984.
  • 7Hirata Y, Hayakawa H, Suzuki Y, et al. Mechanisms of adernomedullin induced vasodilation in the rat kidney. Hypertension,1995, 25:790--795.
  • 8Szokodi I, Kinnunen P, Tavi P, et al. Evidence for cAMP-independent mechanisms mediating the effect of adrenomedullin, a new inotropic peptide. Circulation, 1998, 97 : 1062--1070.
  • 9Ihara T, Ikeda U, Ishibashi S, et al. Postive inotropic effects of adrenomedullin on rat papillary muscle. Eur J Pharmaeol, 2000, 390 :167--172.
  • 10Kobayashi N, Nishikimi T, Horinaka S, et al. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl saltsenstive rats. Atherosclerosis, 2001, 156:255--265.

共引文献153

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部